findmyKOL
Clinical trialNCT02541383CompletedPhase 3Interventional

A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

SponsorIntergroupe Francophone du MyelomeEnrollment1,085Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

107 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Be-Antwerp-Zna Stuivenberg

    Antwerp, Belgium

  • Az St Jan Brugge Oostende Av

    Bruges, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • Ucl Saint-Luc

    Brussels, Belgium

  • Uz Brussel

    Brussels, Belgium

  • Ghdc

    Charleroi, Belgium

  • Uz Gent

    Ghent, Belgium

  • Ch Jolimont

    La Louvière, Belgium

  • University Hospital Leuven

    Leuven, Belgium

  • Domaine Universitaire Du Sart Tilman

    Liège, Belgium

  • Az Delta

    Roeselare, Belgium

  • Az Turnhout

    Turnhout, Belgium

  • Ucl Mont-Godinne

    Yvoir, Belgium

France
  • Chu Amiens Sud

    Amiens, France

  • Chru-Hôpital Du Bocage

    Angers, France

  • Centre Hospitalier D'Argenteuil Victor Dupouy

    Argenteuil, France

  • Centre Hospitalier H.Duffaut

    Avignon, France

  • Centre Hospitalier de la Côte Basque

    Bayonne, France

  • Hôpital Jean Minjoz

    Besançon, France

  • Hôpital Avicenne

    Bobigny, France

  • Polyclinique Bordeaux Nord Acquitaine

    Bordeaux, France

  • Hôpital de Fleyriat

    Bourg-en-Bresse, France

  • Chru Brest - Hôpital A. Morvan

    Brest, France

  • Chu Caen - Côte de Nacre

    Caen, France

  • Clinique Du Parc

    Castelnau-le-Lez, France

  • Ch René Dubos

    Cergy-Pontoise, France

  • Hôpital Privé Sévigné

    Cesson-Sévigné, France

  • Centre Hospitalier William Morey

    Chalon-sur-Saône, France

  • Ch Chambéry

    Chambéry, France

  • Hôpital D'Instruction Des Armées Percy

    Clamart, France

  • Chu D'Estaing

    Clermont-Ferrand, France

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, France

  • Chu Henri Mondor

    Créteil, France

  • Chru Dijon - Hôpital Des Enfants

    Dijon, France

  • Centre Hospitalier Général

    Dunkirk, France

  • Chru Hôpital A. Michallon

    Grenoble, France

  • Chd Vendée

    La Roche-sur-Yon, France

  • Chv André Mignot - Université de Versailles

    Le Chesnay, France

  • Ch de Chartres - Hôpital Louis Pasteur

    Le Coudray, France

  • Centre Hospitalier

    Le Mans, France

67 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
27 Aug 2020
Completion
1 Sept 2023
Last update posted
13 Apr 2025
Registered enrollment
1,085
Registry id
NCT02541383

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-004781-15

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.